Citation Impact
Citing Papers
Rationally Designed Integrin β3 Mutants Stabilized in the High Affinity Conformation
2008 StandoutNobel
Abnormally high thromboxane biosynthesis in homozygous homocystinuria. Evidence for platelet involvement and probucol-sensitive mechanism.
1993
Mechanisms of Thrombus Formation
2008 Standout
A novel arachidonic acid-selective cytosolic PLA2 contains a Ca2+-dependent translocation domain with homology to PKC and GAP
1991 Standout
Vascular dementia
2015 Standout
Preliminary study of the safety and efficacy of SC-58635, a novel cyclooxygenase 2 inhibitor: Efficacy and safety in two placebo-controlled trials in osteoarthritis and rheumatoid arthritis, and studies of gastrointestinal and platelet effects
1998 Standout
Human Fibrinogen
1988
Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial
1998 Standout
New Antithrombotic Drugs
2012
Platelet-Active Drugs
1998
The NOX Family of ROS-Generating NADPH Oxidases: Physiology and Pathophysiology
2007 Standout
Clinical Implications of Prostaglandin and Thromboxane A2Formation
1988
Inactivation of human synovial fluid phospholipase a2 by the marine natural product, manoalide
1990
Platelet Activation and Atherothrombosis
2007 Standout
Antiplatelet Drugs
2012
Role of Oxidative Modifications in Atherosclerosis
2004 Standout
Gastrointestinal Toxicity With Celecoxib vs Nonsteroidal Anti-inflammatory Drugs for Osteoarthritis and Rheumatoid Arthritis
2000 Standout
Chronic kidney disease and cardiovascular risk: epidemiology, mechanisms, and prevention
2013 Standout
COX-2???Specific Inhibitors: Definition of a New Therapeutic Concept
2001
Role of hydroxyl radicals in the activation of human platelets
1994
Randomized Clinical Trial of Daily Aspirin Therapy in Multi‐Infarct Dementia
1989
Initiation of Platelet Adhesion by Arrest onto Fibrinogen or Translocation on von Willebrand Factor
1996 Standout
Clinical Implications of Prostaglandin and Thromboxane A2Formation
1988
A novel moesin-, ezrin-, radixin-like gene is a candidate for the neurofibromatosis 2 tumor suppressor
1993 Standout
Assessment of lipid peroxidation by measuring malondialdehyde (MDA) and relatives in biological samples: Analytical and biological challenges
2016 Standout
Regulatory Functions of the Vascular Endothelium
1990 StandoutNobel
Thromboxane Biosynthesis and Platelet Function in Type II Diabetes Mellitus
1990
Aspirin Dose for the Prevention of Cardiovascular Disease
2007
Low-Dose Aspirin for the Prevention of Atherothrombosis
2005
The Pathogenesis of Coronary Artery Disease and the Acute Coronary Syndromes
1992 Standout
Physical Proximity and Functional Association of Glycoprotein 1bα and Protein-disulfide Isomerase on the Platelet Plasma Membrane
2000
Cyclooxygenase Inhibitors and the Antiplatelet Effects of Aspirin
2001 Standout
COX-2 inhibitors
1999 Standout
The pathogenesis of atherosclerosis: a perspective for the 1990s
1993 StandoutNature
Platelet-Active Drugs
2001
Platelet-Active Drugs: The Relationships Among Dose, Effectiveness, and Side Effects
2004
Stress hyperglycaemia and increased risk of death after myocardial infarction in patients with and without diabetes: a systematic overview
2000 Standout
Prasugrel versus Clopidogrel in Patients with Acute Coronary Syndromes
2007 Standout
Aspirin and other antiplatelet agents in the secondary and primary prevention of cardiovascular disease.
1989
Production of monoclonal antibodies to group A erythrocytes, HLA and other human cell surface antigens-new tools for genetic analysis
1978 Standout
Clopidogrel plus aspirin versus oral anticoagulation for atrial fibrillation in the Atrial fibrillation Clopidogrel Trial with Irbesartan for prevention of Vascular Events (ACTIVE W): a randomised controlled trial
2006 Standout
Leukocyte lipid body formation and eicosanoid generation: cyclooxygenase-independent inhibition by aspirin.
1996 StandoutNobel
Altering Genotype and Phenotype by DNA-Mediated Gene Transfer
1980 StandoutScienceNobel
A herpes simplex virus 1 integration site in the mouse genome defined by somatic cell genetic analysis
1978
Solubilization and properties of Ca2+-dependent human platelet phospholipase A2
1986
Chromosome-mediated gene transfer results in two classes of unstable transformants.
1980
Integrins: Versatility, modulation, and signaling in cell adhesion
1992 Standout
Expression of human genes for adenine phosphoribosyltransferase and hypoxanthine-guanine phosphoribosyltransferase after genetic transformation of mouse cells with purified human DNA
1980
Serial transfer of a human gene to rodent cells by sequential chromosome-mediated gene transfer.
1977
Parameters governing the transfer of the genes for thymidine kinase and dihydrofolate reductase into mouse cells using metaphase chromosomes or DNA
1980
Selective inhibition of inducible cyclooxygenase 2 in vivo is antiinflammatory and nonulcerogenic.
1994 Standout
Role of platelet membrane glycoprotein IIb-IIIa in agonist-induced tyrosine phosphorylation of platelet proteins.
1990
DNA-mediated transfer of the adenine phosphoribosyltransferase locus into mammalian cells.
1979 StandoutNobel
Low dose aspirin and inhibition of thromboxane B2 production in healthy subjects
1980
Cotransfer of circular and linear prokaryotic and eukaryotic DNA sequences into mouse cells.
1980
IMPROVED AORTOCORONARY BYPASS PATENCY BY LOW-DOSE ASPIRIN (100 mg DAILY)
1984
[9] Purification of PGH synthase from sheep vesicular glands
1982
Effects of Antiplatelet Therapy on Mortality and Cardiovascular and Bleeding Outcomes in Persons With Chronic Kidney Disease
2012
Monitoring the entry of new platelets into the circulation after ingestion of aspirin
1983
Biological actions and properties of endothelium-derived nitric oxide formed and released from artery and vein.
1989 StandoutNobel
Aspirin and Other Platelet-Active Drugs
1992
Identification of antigen-presenting dendritic cells in mouse aorta and cardiac valves
2009 StandoutNobel
Urinary excretion of 2,3-dinor-thromboxane B2 in man under normal conditions, following drugs and during some pathological conditions
1984
1 Arachidonate Metabolism in Blood Cells and the Vessel Wall
1986
Reconstitution of the purified platelet fibrinogen receptor. Fibrinogen binding properties of the glycoprotein IIb-IIIa complex.
1985
Inhibition of adriamycin‐induced human platelet lipid peroxidation by vitamin E
1978
ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease
2006 Standout
Phenotype stabilisation and integration of transferred material in chromosome-mediated gene transfer
1979 Nature
Endogenous biosynthesis of prostacyclin and thromboxane and platelet function during chronic administration of aspirin in man.
1983
Relationship between Secretion of Platelet Factor 4 and Thrombin Generation during In Vitro Blood Clotting
1980
EIGHTH GADDUM MEMORIAL LECTURE UNIVERSITY OF LONDON INSTITUTE OF EDUCATION DECEMBER 1980: BIOLOGICAL IMPORTANCE OF PROSTACYCLIN
1982
Cotransfer of two linked human genes into cultured mouse cells.
1976
Self-Assembled Organic Monolayers: Model Systems for Studying Adsorption of Proteins at Aurfaces
1991 StandoutScience
Transforming DNA integrates into the host chromosome
1981 StandoutNobel
Role of Prostacyclin in the Cardiovascular Response to Thromboxane A 2
2002 StandoutScience
High efficiency transformation by direct microinjection of DNA into cultured mammalian cells
1980 StandoutNobel
A murine monoclonal antibody that completely blocks the binding of fibrinogen to platelets produces a thrombasthenic-like state in normal platelets and binds to glycoproteins IIb and/or IIIa.
1983
Platelet survival and the development of coronary artery disease in the young adult: effects of cigarette smoking, strong family history and medical therapy.
1981
Blood pressure, stroke, and coronary heart disease
1990 Standout
Ibuprofen protects platelet cyclooxygenase from irreversible inhibition by aspirin.
1983
Adventures in vascular biology: a tale of two mediators
2006
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
2014 Standout
The Status of the Gene Map of the Human Chromosomes
1977 Science
Oral Rivaroxaban for the Treatment of Symptomatic Pulmonary Embolism
2012 Standout
Cancer Chemopreventive Activity of Resveratrol, a Natural Product Derived from Grapes
1997 StandoutScience
Clinical pharmacology of platelet cyclooxygenase inhibition.
1985
Distinct variants of erythrocyte protein 4.1 inherited in linkage with elliptocytosis and Rh type in three white families
1988 StandoutNobel
Coordinate modulation of transfected HSV thymidine kinase and human globin genes
1983 StandoutNobel
DIFFERENTIAL INHIBITION BY LOW-DOSE ASPIRIN OF HUMAN VENOUS PROSTACYCLIN SYNTHESIS AND PLATELET THROMBOXANE SYNTHESIS
1981
Increased thromboxane biosynthesis in type IIa hypercholesterolemia.
1992
The International Stroke Trial (IST): a randomised trial of aspirin, subcutaneous heparin, both, or neither among 19 435 patients with acute ischaemic stroke
1997 Standout
DIFFERENTIAL INHIBITION OF PROSTACYCLIN PRODUCTION AND PLATELET AGGREGATION BY ASPIRIN
1979
Role in translation of a triple tandemly repeated sequence in the 5′-untranslated region of human thymidylate synthase mRNA
1987 StandoutNobel
The Anthracycline Antineoplastic Drugs
1981 Standout
Arachidonic Acid Metabolites and the Interactions between Platelets and Blood-Vessel Walls
1979 StandoutNobel
Phospholipase A2Enzymes: Physical Structure, Biological Function, Disease Implication, Chemical Inhibition, and Therapeutic Intervention
2011 Standout
Inhibition of Prostacyclin and Platelet Thromboxane A2after Low-Dose Aspirin
1981
Efficient gene transfer in C.elegans: extrachromosomal maintenance and integration of transforming sequences.
1991 StandoutNobel
Acetylation of Prostaglandin Endoperoxide Synthetase with Acetylsalicylic Acid
1980
Selective Cumulative Inhibition of Platelet Thromboxane Production by Low-dose Aspirin in Healthy Subjects
1982 Standout
Increased thromboxane biosynthesis in patients with acute cerebral ischemia.
1993
Molecular pharmacology of manoalide
1986
The biology of platelet-derived growth factor
1986 Standout
DIPYRIDAMOLE AND OTHER PHOSPHODIESTERASE INHIBITORS ACT AS ANTITHROMBOTIC AGENTS BY POTENTIATING ENDOGENOUS PROSTACYCLIN
1978
Synthesis of Prostacyclin from Platelet-derived Endoperoxides by Cultured Human Endothelial Cells
1980
Aspirin and other platelet active drugs. Relationship among dose, effectiveness, and side effects.
1989
Cell cycle-dependent regulation of thymidine kinase activity introduced into mouse LMTK- cells by DNA and chromatin-mediated gene transfer.
1981
New Perspectives in Cell Adhesion: RGD and Integrins
1987 StandoutScience
Works of John W. Burch being referenced
Glutathione disulfide production during arachidonic acid oxygenation in human platelets
1990
Modification of glutathione content in platelet concentrates by the use of acivicin
1994
Direct interaction of mepacrine with erythrocyte and platelet membrane phospholipid.
1982
Cotransfer of thymidine kinase and galactokinase genes by chromosome-mediated gene transfer.
1978
Prevention of Thrombosis in Patients on Hemodialysis by Low-Dose Aspirin
1979
A role for prostaglandins and thromboxanes in the exposure of platelet fibrinogen receptors.
1981
Sensitivity of fatty acid cyclooxygenase from human aorta to acetylation by aspirin.
1978
The role of prostaglandins in platelet function.
1979
Inhibition of platelet prostaglandin synthetase by oral aspirin.
1978
Human gene expression in rodent cells after uptake of isolated metaphase chromosomes.
1975